For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback